Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention

Lecrenier, Nicolas; Beukelaers, Pierre; Colindres, Romulo; Curran, Desmond; De Kesel, Carine; De Saegher, Jean-Philippe; Didierlaurent, Arnaud; Ledent, Edouard Y; Mols, Johann F; Mrkvan, Tomas; Normand-Bayle, Marie; Oostvogels, Lidia; Da Silva, Fernanda Tavares; Vassilev, Ventzislav; Vinals, Carlota; Brecx, Alain

doi:10.1080/14760584.2018.1495565

Scientific article

Review

English

Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention

ContributorsLecrenier, Nicolas; Beukelaers, Pierre; Colindres, Romulo; Curran, Desmond; De Kesel, Carine; De Saegher, Jean-Philippe; Didierlaurent, Arnaud

; Ledent, Edouard Y; Mols, Johann F; Mrkvan, Tomas; Normand-Bayle, Marie; Oostvogels, Lidia; Da Silva, Fernanda Tavares; Vassilev, Ventzislav; Vinals, Carlota; Brecx, Alain

Published inExpert Review of Vaccines, vol. 17, no. 7, p. 619-634

Publication date2018

Affiliation Not a UNIGE publication

Research group

Laboratoire d'immunologie vaccinale humaine (1025)

Citation (ISO format)

LECRENIER, Nicolas et al. Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention. In: Expert Review of Vaccines, 2018, vol. 17, n° 7, p. 619–634. doi: 10.1080/14760584.2018.1495565

Article (Published version)

Identifiers

PID : unige:143069
DOI : 10.1080/14760584.2018.1495565
PMID : 30028651

Commercial URLhttps://www.tandfonline.com/doi/full/10.1080/14760584.2018.1495565

ISSN of the journal1476-0584

206views

1downloads

Creation10/12/2020 2:43:00 PM

First validation10/12/2020 2:43:00 PM

Update time03/15/2023 10:46:13 PM

Status update03/15/2023 10:46:12 PM

Last indexation08/30/2023 11:40:03 PM

Archive ouverte UNIGE

Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention

Technical informations